Jason Mehar

Senior Vice President, Investments & Deputy General Counsel at Royalty Pharma

Jason Mehar has extensive work experience in the legal and investment fields. Jason is currently employed as the Vice President of Investments and Deputy General Counsel at Royalty Pharma since April 2018. Prior to that, they worked as an Associate in Mergers & Acquisitions at Gibson, Dunn & Crutcher LLP from April 2014 to March 2018. Jason also worked as an Associate in Mergers & Acquisitions at Davis Polk & Wardwell LLP from September 2009 to April 2014. Additionally, they served as Counsel in Structured Products at Credit Suisse from January 2011 to June 2011. Jason Mehar began their legal career as a Summer Associate at Davis Polk & Wardwell LLP in May 2008.

Jason Mehar completed their Bachelor of Arts degree in Business at York University from 2002 to 2006. Jason then pursued their Doctor of Law (JD) degree at York University - Osgoode Hall Law School from 2006 to 2009. In addition, they obtained a Bar Admission in the State of New York, although the specific month and year of its acquisition are not provided.

Links

Previous companies

Credit Suisse logo

Org chart

Timeline

  • Senior Vice President, Investments & Deputy General Counsel

    January 1, 2024 - present

  • Vice President Investments Deputy General Counsel

    April, 2018

View in org chart